Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference

Integra LifeSciences (Nasdaq: IART) said CEO Mojdeh Poul and CFO Lea Knight will present at the 44th Annual J.P.

Rhea-AI Summary

Integra LifeSciences (Nasdaq: IART) said CEO Mojdeh Poul and CFO Lea Knight will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 at 2:15 p.m. ET (11:15 a.m. PT).

A live webcast of the presentation will be available on Integra LifeSciences' investor relations website under Events & Presentations.

Argus Jan 6 session

+4.54% close to close Open Argus

Details

News Market Reaction – IART

In the Jan 6 session, IART gained 4.54%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Integra leadership presenting at the 44th Annual J.P. Morgan Healthcare...

Analysis

This announcement highlights Integra leadership presenting at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, providing another venue to reiterate strategy and discuss prior milestones such as Q3 2025 results and recent FDA 510(k) clearance. Similar conference updates have previously produced only modest stock moves. Investors may focus on how management frames growth, reimbursement tailwinds, and balance-sheet considerations, with upcoming earnings releases and SEC filings offering the most concrete data to monitor.

Key Figures

Conference edition: 44th Presentation date: January 14, 2026 Presentation time ET: 2:15 p.m. ET +1 more

Conference edition

44th

44th Annual J.P. Morgan Healthcare Conference

Presentation date

January 14, 2026

J.P. Morgan Healthcare Conference presentation date

Presentation time ET

2:15 p.m. ET

Scheduled IART presentation time

Presentation time PT

11:15 a.m. PT

Scheduled IART presentation time

Historical Context

5 past events · Latest: Dec 01

5 events

1. Dec 01

   Conference appearance

   24h Move

   +0.8%

   Management presenting at Citi 2025 Global Healthcare Conference with webcast access.

2. Nov 25

   Policy/reimbursement

   24h Move

   +6.2%

   Medicare rules including all Integra skin substitutes with uniform reimbursement rates.

3. Nov 11

   Regulatory clearance

   24h Move

   +1.2%

   FDA 510(k) clearance expanding CUSA Clarity use to cardiac surgeries debridement.

4. Oct 30

   Earnings release

   24h Move

   -23.5%

   Q3 2025 revenue and EPS growth with updated full-year guidance and relaunch actions.

5. Oct 15

   Earnings call notice

   24h Move

   -1.2%

   Scheduling of Q3 2025 results release and conference call with webcast details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m ET or 11:15 a.m PT

A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.

About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com   

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com 

Integra LifeSciences Holdings Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Integra LifeSciences (IART) present at the J.P. Morgan Healthcare Conference?

Integra will present on January 14, 2026 at 2:15 p.m. ET (11:15 a.m. PT).

Who from Integra LifeSciences (IART) will present at the January 14, 2026 J.P. Morgan conference?

Chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present.

How can investors watch Integra LifeSciences (IART) presentation on January 14, 2026?

A live webcast will be available on the Integra LifeSciences investor relations website under Events & Presentations.

What topics will Integra LifeSciences (IART) cover at the 44th Annual J.P. Morgan Healthcare Conference?

The company announced the presenters and timing; specific presentation topics were not disclosed in the announcement.

Will Integra LifeSciences (IART) provide a replay of the January 14, 2026 presentation?

The announcement states a live webcast will be available; replays are typically posted on the investor relations Events & Presentations page following the event.